Pharmaceuticals

India’s pharmaceutical industry has undergone a comprehensive regulatory overhaul spearheaded by the nation’s apex health regulatory agency and its chief,

Mumbai: As the nation is gearing up to welcome the new year 2024, the Indian pharma sector in 2023 traversed

The total outlay of the scheme is Rs 15,000 crore and the scheme duration is from 2020-2021 to 2028-29, an

The level of competition in the Russian pharmaceutical market will significantly tighten next year, as local drugmakers plan to overtake

As technology advances and regulatory scrutiny intensifies, it is critical to ensure the safety and authenticity of pharmaceutical products across

New Delhi: AstraZeneca said on Tuesday it will buy Gracell Biotechnologies for up to $1.2 billion as the Anglo-Swedish pharma

As the new year beckons, the pharmaceutical industry is poised for more developments, building on advances made in 2023. The

New Zealand: The U.S. Food and Drug Administration (FDA) declined to approve Zealand Pharma’s drug for the prevention and treatment

India’s Maiden Pharmaceuticals, whose cough syrups have been linked to the deaths of children in Gambia, on Saturday denied it

AstraZeneca and Ionis’ Wainua (eplontersen) has been approved in the US for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in